GLP-1 drugs may have a beneficial effect across many types of cancer - Yahoo
Recent studies presented at the American Society of Clinical Oncology suggest that GLP-1 weight-loss and diabetes drugs may offer protective benefits against various cancers. Researchers believe these medications could reduce cancer risk and improve patient outcomes by lowering inflammation and regulating insulin signaling.
Why it matters
This finding could significantly shift the clinical understanding of GLP-1 drugs, moving them from purely metabolic treatments to potential preventative tools in oncology.
FILE PHOTO: A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey/File Photo FILE PHOTO: A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo FILE PHOTO: A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo 1 of 2 FILE PHOTO: A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey/File Photo By Nancy Lapid
The article reports on scientific findings presented at a professional conference without taking a stance or using loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in